A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

According to the American Cancer Society, colorectal cancer is the second leading cause of cancer death. Enrichment of regulatory T cells (T-regs) in solid cancers is generally associated with poor ...

Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...

Scientists have discovered that cells can sense far beyond the surfaces they touch. While individual cancer cells can probe about 10 microns ahead by tugging on surrounding collagen fibers, clusters ...

Bioengineers have developed a platform that accurately replicates conditions cancer cells encounter while traveling through ...

Small cell lung cancer is one of the most aggressive forms of cancer. It grows quickly and spreads early, which makes it very difficult to treat. Even though patients often respond well to ...

B-cell acute lymphoblastic leukaemia is the most common form of childhood cancer. In this type of cancer, which affects blood ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...